Niki BioSolutions, Inc. (NIKI)
About Niki BioSolutions, Inc. (NIKI)
Niki BioSolutions Inc, formerly Aptorum Group Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA).
- 2
- 2018
- XNAS
90-Day SEC Filing Activity
No Form 4 activity for NIKI in the last 90 days.
NIKI Insider Transactions (Form 4)
0No Form 4 filings for NIKI yet.
Transactions appear here automatically as insiders file with the SEC.
Recent NIKI Form 8-K Filings
4NIKI Insider Trading - FAQ
Where can I see NIKI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks NIKI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow NIKI insider buys?
Create a free InsiderAlpha account and press Watch on this page to add NIKI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity by sector
- Where buying and selling is concentrated across the eleven GICS sectors.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track NIKI insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
